Heart MRI reveals clues about fabry disease treatment
NCT ID NCT02956954
First seen Feb 06, 2026 · Last updated May 05, 2026 · Updated 10 times
Summary
This study followed 26 adults with Anderson-Fabry disease to see how their heart tissue changes over time using a special MRI technique called T1 mapping. Some participants were already taking the enzyme replacement therapy Replagal®, while others were not. The goal was to learn whether T1 mapping can show if the treatment is helping the heart, rather than to test a new cure or therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDERSON FABRY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rouen University Hospital
Rouen, France
Conditions
Explore the condition pages connected to this study.